Yeast as a model for studying Alzheimer's disease

被引:44
作者
Bharadwaj, Prashant [2 ,3 ]
Martins, Ralph [2 ,4 ,5 ]
Macreadie, Ian [1 ,2 ]
机构
[1] Univ Melbourne, Sienna Canc Diagnost, Inst Bio21, Parkville, Vic 3010, Australia
[2] Edith Cowan Univ, Ctr Excellence Alzheimers Dis Res & Care, Sch Exercise Biomed & Hlth Sci, Perth, WA, Australia
[3] CSIRO Mol & Hlth Technol & P Hlth Flagship, Parkville, Vic, Australia
[4] Hollywood Private Hosp, Sir James McCusker Alzheimers Dis Res Unit, Nedlands, WA, Australia
[5] Univ Western Australia, Sch Psychiat & Clin Neurosci, Crawley, WA, Australia
基金
欧盟地平线“2020”;
关键词
Alzheimer's disease; amyloid A beta; tau phosphorylation; toxic protein oligomerization; neurotoxicity; AMYLOID-BETA PEPTIDE; C-TERMINAL FRAGMENT; PRECURSOR PROTEIN; GAMMA-SECRETASE; COGNITIVE IMPAIRMENT; OXIDATIVE DAMAGE; APOLIPOPROTEIN-E; TAU-PROTEIN; BRAIN; IDENTIFICATION;
D O I
10.1111/j.1567-1364.2010.00658.x
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Alzheimer's disease (AD) is a progressive neurodegenerative disorder characterized by acute cognitive decline. The AD brain is featured by extracellular senile amyloid plaques, intraneuronal neurofibrillary tangles and extensive neuronal cell loss in specific regions of the brain associated with memory. The exact mechanism of neuronal cell dysfunction leading to the memory loss in AD is poorly understood. A number of studies have indicated that yeast is a suitable model system to decipher the molecular mechanisms involved in a variety of neurodegenerative disorders caused by pathological protein misfolding and deposition. Here, the knowledge from various studies that have utilized a yeast model to study the mechanism of pathways involved in AD pathogenesis is summarized.
引用
收藏
页码:961 / 969
页数:9
相关论文
共 84 条
[1]   Inhibitors of protein aggregation and toxicity [J].
Amijee, Hozefa ;
Madine, Jill ;
Middleton, David A. ;
Doig, Andrew J. .
BIOCHEMICAL SOCIETY TRANSACTIONS, 2009, 37 :692-696
[2]   Prediction of transition from cognitive impairment to senile dementia: a prospective, longitudinal study [J].
Artero, S ;
Tierney, MC ;
Touchon, J ;
Ritchie, K .
ACTA PSYCHIATRICA SCANDINAVICA, 2003, 107 (05) :390-393
[3]   Genetics of Alzheimer's disease: recent advances [J].
Avramopoulos, Dimitrios .
GENOME MEDICINE, 2009, 1
[4]   Modulation of Aβ42 low-n oligomerization using a novel yeast reporter system [J].
Bagriantsev, Sviatoslav ;
Liebman, Susan .
BMC BIOLOGY, 2006, 4 (1)
[5]   Yeast genes and human disease [J].
Bassett, DE ;
Boguski, MS ;
Hieter, P .
NATURE, 1996, 379 (6566) :589-590
[6]   Polyphenols as potential inhibitors of amyloid aggregation and toxicity: Possible significance to Alzheimer's disease [J].
Bastianetto, S. ;
Krantic, S. ;
Quirion, R. .
MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2008, 8 (05) :429-435
[7]  
Bergem ALM, 1997, ARCH GEN PSYCHIAT, V54, P264
[8]  
Bharadwaj P, 2008, J ALZHEIMERS DIS, V13, P147
[9]   Aβ aggregation and possible implications in Alzheimer's disease pathogenesis [J].
Bharadwaj, Prashant R. ;
Dubey, Ashok K. ;
Masters, Colin L. ;
Martins, Ralph N. ;
Macreadie, Ian G. .
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2009, 13 (03) :412-421
[10]   NEUROPATHOLOGICAL STAGING OF ALZHEIMER-RELATED CHANGES [J].
BRAAK, H ;
BRAAK, E .
ACTA NEUROPATHOLOGICA, 1991, 82 (04) :239-259